Olema Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
OLMA on Nasdaq
Industry
Pharmaceutical Preparations
Location
780 Brannan Street, San Francisco, CA

Insiders trading volume in the past year

Olema Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paradigm Biocapital Advisors LP 10%+ Owner $174M -$34.6M -16.6% Aug 1, 2024
Cyrus Harmon Director $13.6M -$2.49M -15.5% Jul 29, 2024
G. Walmsley Graham Director $10.5M -$15.6M -59.7% Jun 14, 2024
Bvf Partners L P/Il Director, 10%+ Owner $9.26M Jun 14, 2024
David C. Myles Ch. Discov. & Non Clin Dev Off $5.12M -$200K -3.76% Feb 1, 2024
Andrew Rappaport Director $5.02M Jun 14, 2024
Shane Kovacs Ch. Operating & Financial Off. $3.4M -$270K -7.34% Feb 1, 2024
Sean Bohen PRESIDENT AND CEO, Director $1.02M -$824K -44.8% Feb 1, 2024
Naseem Zojwalla Chief Medical Officer $981K -$209K -17.6% May 24, 2024
John B. Moriarty EVP, Ch. Legal Officer & Sec. Feb 1, 2023
Yi Larson Director Jun 14, 2024
Peter J. Kushner Chief Scientific Officer Feb 1, 2022
Cynthia M. Butitta Director Jun 14, 2024
Kinney Horn Chief Business Officer Feb 1, 2023
Gorjan Hrustanovic Director Jun 14, 2024
Ian T. Clark Director Jun 14, 2024
J. Scott Garland Director Jun 14, 2024
Sandra Horning Director Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Olema Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.